CHARACTERIZING THE MANAGEMENT OF PATIENTS WITH NASH (WITH VERSUS WITHOUT CIRRHOSIS) IN REAL-WORLD CLINICAL PRACTICE: RARE ASSESSMENT BY HEPATOLOGISTS AND LOW FREQUENCY OF IMAGING

被引：0
|
作者：
Qian, Christina [1 ]
Charlton, Michael R. [2 ]
Szabo, Shelagh M. [1 ]
Sun, Rosie [1 ]
Rochon, Hannah [1 ]
Fishman, Jesse [3 ]
机构：
[1] Broadstreet Heor, Vancouver, BC, Canada
[2] Univ Chicago, Chicago, IL USA
[3] Madrigal Pharmaceut, W Conshohocken, PA USA
来源：
HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2149-A
引用
收藏
页码：S927 / S928
页数：2
相关论文
共 50 条
  • [1] REAL-WORLD EVALUATION OF NASH IN US CLINICAL PRACTICE: UNDERUTILIZATION OF LIVER BIOPSY AND LIVER IMAGING
    Lai, Michelle
    Milligan, Scott
    Wick, Nicole M.
    Younossi, Zobair M.
    Afdhal, Nezam H.
    GASTROENTEROLOGY, 2019, 156 (06) : S1223 - S1223
  • [2] Comorbidity severity scores and cardiovascular comorbidities in patients with non-alcoholic steatohepatitis (NASH), with and without cirrhosis, in a real-world setting
    Lazarus, Jeffrey
    Chandramouli, Abhishek Shankar
    Mangla, Kamal Kant
    Younossi, Zobair
    JOURNAL OF HEPATOLOGY, 2022, 77 : S148 - S149
  • [3] CLINICAL CHARACTERISTICS FROM A REAL-WORLD POPULATION OF NASH PATIENTS: FINDINGS FROM THE GAIN (GLOBAL ASSESSMENT OF THE IMPACT OF NASH) SOCIOECONOMIC STUDY
    Rose, A.
    Russell, T.
    Ruiz, L.
    O'Hara, J.
    Morgan, G.
    Franks, B.
    VALUE IN HEALTH, 2019, 22 : S160 - S161
  • [4] Characteristics and Costs of NASH Advanced Fibrosis and Cirrhosis in Patients with and without Diabetes Mellitus (DM): Results of a US Real-World Cohort Study
    Sanyal, Arun J.
    Bengtson, Lindsay
    Shreay, Sanatan
    Kim, W. Ray
    HEPATOLOGY, 2017, 66 : 1168A - 1169A
  • [5] CHARACTERISTICS OF MIGRAINE PATIENTS WITH MIGRAINE DISABILITY ASSESSMENT (MIDAS) SCORES IN REAL-WORLD CLINICAL PRACTICE
    Chia, V. M.
    Thach, A.
    Yusuf, A.
    Kallenbach, L.
    Bogdanov, A.
    VALUE IN HEALTH, 2019, 22 : S286 - S286
  • [6] Characteristics and management of cancer patients with systolic left ventricular dysfunction in real-world clinical practice
    Ammon, M.
    Leibundgut, G.
    Kaufmann, B.
    Pfister, O.
    EUROPEAN HEART JOURNAL, 2010, 31 : 567 - 567
  • [7] Lenvatinib with or without immune checkpoint inhibitors for patients with unresectable hepatocellular carcinoma in real-world clinical practice
    Kang Chen
    Wei Wei
    Lei Liu
    Zhu-Jian Deng
    Le Li
    Xiu-Mei Liang
    Ping-Ping Guo
    Lu-Nan Qi
    Zhi-Ming Zhang
    Wen-Feng Gong
    Shan Huang
    Wei-Ping Yuan
    Liang Ma
    Bang-De Xiang
    Le-Qun Li
    Jian-Hong Zhong
    Cancer Immunology, Immunotherapy, 2022, 71 : 1063 - 1074
  • [8] Lenvatinib with or without immune checkpoint inhibitors for patients with unresectable hepatocellular carcinoma in real-world clinical practice
    Chen, Kang
    Wei, Wei
    Liu, Lei
    Deng, Zhu-Jian
    Li, Le
    Liang, Xiu-Mei
    Guo, Ping-Ping
    Qi, Lu-Nan
    Zhang, Zhi-Ming
    Gong, Wen-Feng
    Huang, Shan
    Yuan, Wei-Ping
    Ma, Liang
    Xiang, Bang-De
    Li, Le-Qun
    Zhong, Jian-Hong
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (05) : 1063 - 1074
  • [9] Dyslipidemia treatment patterns and low-density lipoprotein cholesterol monitoring and management of patients with atherosclerosis in real-world clinical practice
    Fox, Kathleen M.
    Gandhi, Sanjay K.
    Blasetto, James W.
    Ohsfeldt, Robert L.
    Grandy, Susan
    Davidson, Michael H.
    CIRCULATION, 2007, 115 (21) : E572 - E572
  • [10] Management of cardiovascular risk in women with and without menopausal symptoms: A real-world depiction of clinical practice in the UK and France
    Chu, Paula
    Goodall, Gordon
    Avella, Jairo Alberto
    Storelli, Stefania
    Gale, Chris
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 396 - 396
12345